The selling picked up the pace in the stock market today after a mixed jobs report, but there were plenty of earnings winners ...

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

The Dow Jones shed 300 points after US NFP figures missed the mark. US consumer inflation fears rose, while their outlook deteriorated. US President Donald Trump puts tariffs back on the board. The ...